Study Evaluating the Effect of R-mabHDI in Lymphocytic Predominant Hodgkin's Lymphoma

This study is not yet open for participant recruitment.
Verified July 2011 by American Scitech International
Sponsor:
Collaborators:
ImClone LLC
Bristol-Myers Squibb
Information provided by:
American Scitech International
ClinicalTrials.gov Identifier:
NCT00816959
First received: January 5, 2009
Last updated: July 19, 2011
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: April 2014
  Estimated Primary Completion Date: April 2014 (Final data collection date for primary outcome measure)